Pediatric Sickle Cell Disease
Showing 1 - 25 of >10,000
VO2max & HRQoL in Children With Sickle Cell Disease
Completed
- Sickle Cell
- Children
-
Montpellier, Occitanie, FrancePediatric and Congenital Cardiology Department, Arnaud De Villen
Aug 16, 2023
Sickle Cell Disease Trial in Milwaukee (Passport Card, No Passport card)
Completed
- Sickle Cell Disease
- Passport Card
- No Passport card
-
Milwaukee, Wisconsin
- +1 more
Apr 4, 2022
Sickle Cell Disease Trial in Atlanta, Cincinnati (I-STRONG for SCD)
Recruiting
- Sickle Cell Disease
- I-STRONG for SCD
-
Atlanta, Georgia
- +1 more
Oct 26, 2023
Sickle Cell Disease, Pain Trial in Washington (The Balance Program)
Recruiting
- Sickle Cell Disease
- Pain
- The Balance Program
-
Washington, District of ColumbiaChildren's National Hospital
Dec 13, 2021
Sickle Cell Disease Trial in Little Rock (GBT021601)
Recruiting
- Sickle Cell Disease
-
Little Rock, ArkansasLynn Institute of the Ozarks
Aug 10, 2022
Sickle Cell Disease, Hydroxyurea Failure, Hydroxyurea Intolerance Trial in Nashville (CTX001)
Recruiting
- Sickle Cell Disease
- +4 more
- CTX001
-
Philadelphia, Pennsylvania
- +3 more
Jan 24, 2023
Anemia, Sickle Cell Trial in Indianapolis (Types of Telemedicine Delivery Models)
Recruiting
- Anemia, Sickle Cell
- Types of Telemedicine Delivery Models
-
Indianapolis, IndianaIndiana University
Jul 28, 2022
Near Infrared Spectroscopy in Sickle Cell Pediatric Patients
Recruiting
- Sickle Cell Disease
- Near infrared spectroscopy
-
Washington, District of ColumbiaChildren's National Medical Center
Mar 31, 2022
Sickle Cell Disease Trial in Orbassano
Completed
- Sickle Cell Disease
-
Orbassano, Torino, ItalyAOU San Luigi Gonzaga
Jan 10, 2022
Hemoglobinopathies, Thalassemia, Sickle Cell Disease Trial in Banha (Hemoglobinopathy Nursing Program)
Completed
- Hemoglobinopathies
- +3 more
- Hemoglobinopathy Nursing Program
-
Banhā, Other, EgyptBenha University
May 21, 2022
Sickle Cell Disease Trial in Dallas (Single Session Problem-Solving Intervention)
Completed
- Sickle Cell Disease
- Single Session Problem-Solving Intervention
-
Dallas, TexasChildren's Medical Center
Mar 18, 2022
Sickle Cell Disease Trial in France (pediatric-adult care transition program)
Recruiting
- Sickle Cell Disease
- pediatric-adult care transition program
-
Fort-de-France-La Martinique, La Martinique, France
- +7 more
Apr 14, 2022
Obesity in Pediatric Sickle Cell Disease: A New Phenomenon
Recruiting
- Sickle Cell Disease
- +4 more
-
Jackson, MississippiUniversity of Mississippi Medical Center
Apr 28, 2021
Sickle Cell Disease, Hemechip
Completed
- Sickle Cell Disease
-
Omaha, Nebraska
- +6 more
May 19, 2022
Sickle Cell Disease, GVHD Trial in United States (Diphenhydramine, Acetaminophen, Methylprednisolone)
Active, not recruiting
- Sickle Cell Disease
- Graft Versus Host Disease
- Diphenhydramine
- +15 more
-
Washington, District of Columbia
- +6 more
Aug 4, 2021
Pain Management Protocol for Pediatric Sickle Cell Disease
Completed
- Sickle Cell Disease
- Brief Cognitive-Behavioral Pain Management Training
-
Columbia, South CarolinaChildren's Cancer and Blood Disorder
Apr 27, 2021
Sickle Cell Anemia, Beta-thalassemia Major, Diamond-blackfan Anemia Trial in Pittsburgh (CD3/CD19 depleted leukocytes, CD45RA
Recruiting
- Sickle Cell Anemia
- +2 more
- CD3/CD19 depleted leukocytes
- +6 more
-
Pittsburgh, PennsylvaniaChildren's Hospital of Pittsburgh of UPMC
May 4, 2022
Child, Only, Brain Diseases, Sickle Cell Disease Trial in Saint Louis (Carbon Dioxide)
Recruiting
- Child, Only
- +3 more
- Carbon Dioxide
-
Saint Louis, MissouriWashington University in St. Louis
Mar 27, 2022
Sickle Cell Disease, Thalassemia Trial in Memphis (Hydroxyurea, Hydroxyurea Oral Capsule)
Terminated
- Sickle Cell Disease
- Thalassemia
- Hydroxyurea
- Hydroxyurea Oral Capsule
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Feb 18, 2022
Sickle Cell Disease Trial in Boston (WE CARE SDoH Screening Survey, Family Resource Book, Standard of care)
Enrolling by invitation
- Sickle Cell Disease
- WE CARE SDoH Screening Survey
- +2 more
-
Boston, MassachusettsBoston Medical Center
Jan 18, 2022
Sickle Cell Disease Trial in Baltimore (Voxelotor Only Product in Oral Dose Form, Placebo)
Recruiting
- Sickle Cell Disease
- Voxelotor Only Product in Oral Dose Form
- Placebo
-
Baltimore, MarylandUniversity of Maryland Medical Center
Jan 27, 2022
Sickle Cell Disease, Vaso-Occlusive Pain Episode in Sickle Cell Disease, Vaso-occlusive Crisis Trial in Bronx (Intranasal
Recruiting
- Sickle Cell Disease
- +5 more
- Intranasal ketamine
-
Bronx, New York
- +1 more
Aug 31, 2021
Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem
Active, not recruiting
- Hematologic Malignancies
- +7 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 28, 2022